← All stocks

Metagenomi Therapeutics, Inc.

MGX Net buying
CIK 0001785279 #4736 in the set updated 17 Sep 2026
Bought (120 mo)
$13.05M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$112.48K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$112.48K
26 of 26 sales
Net
+$12.94M
+$12.94M against sales at will

By person

12 insiders · 30 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Novo Holdings A/S entity
10% owner
$13.03M (2)
+$13.03M
1,739,175
$2.05M
Wapnick Pamela
Chief Financial Officer
$41.23K (9)
−$41.23K
206,580
$243.76K
Thomas Brian C.
Director
$30.55K (3)
−$30.55K
2,510,960
$2.96M
+5.6%
Irish Jian
See Remarks
$26.83K (6)
−$26.83K
668,106
$788.37K
+27.1%
Reid Laurence
Director
$23.40K (2)
+$23.40K
20,000
$23.60K
Noonberg Sarah B.
Chief Medical Officer
$9.17K (1)
−$9.17K
109,135
$128.78K
+156.1%
Wein Matthew
See Remarks
$4.72K (7)
−$4.72K
126,133
$148.84K
+2,878%
BAYER HEALTHCARE LLC entity
10% owner
4,050,997
$4.78M
Bernales Sebastian
Director
2,666,290
$3.15M
+938.1%
Harnest Simon
See Remarks
122,664
$144.74K
+10.4%
Delaney Simren
See Remarks
93,892
$110.79K
+8.0%
Borges Luis
Chief Scientific Officer
69,316
$81.79K

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Insider
Date
Role
Action
Shares
Price
Amount
Wapnick Pamela
8 Sep 2026
Chief Financial Officer
Sell
1,911
$1.16
$2.21K
Irish Jian
8 Sep 2026
See Remarks
Sell
2,140
$1.16
$2.48K
Wein Matthew
8 Sep 2026
See Remarks
Sell
358
$1.16
$414.71
Wein Matthew
5 Jun 2026
See Remarks
Sell
558
$1.30
$724.84
Irish Jian
5 Jun 2026
See Remarks
Sell
3,737
$1.30
$4.85K
Wapnick Pamela
5 Jun 2026
Chief Financial Officer
Sell
2,884
$1.30
$3.75K
Irish Jian
5 Mar 2026
Chief Executive Officer
Sell
1,607
$1.60
$2.57K
Wein Matthew
5 Mar 2026
See Remarks
Sell
482
$1.60
$771.20
Wapnick Pamela
5 Mar 2026
Chief Financial Officer
Sell
1,581
$1.60
$2.53K
Irish Jian
5 Dec 2025
Chief Executive Officer
Sell
1,602
$1.77
$2.84K
Wapnick Pamela
5 Dec 2025
Chief Financial Officer
Sell
1,576
$1.77
$2.79K
Wein Matthew
5 Dec 2025
See Remarks
Sell
199
$1.77
$352.61
Thomas Brian C.
5 Dec 2025
Director
Sell
3,830
$1.77
$6.79K
Wein Matthew
5 Sep 2025
See Remarks
Sell
199
$1.81
$360.19
Irish Jian
5 Sep 2025
Chief Executive Officer
Sell
1,602
$1.81
$2.90K
Wapnick Pamela
5 Sep 2025
Chief Financial Officer
Sell
1,576
$1.81
$2.85K
Thomas Brian C.
5 Sep 2025
Director
Sell
2,701
$1.81
$4.89K
Irish Jian
6 Jun 2025
See Remarks
Sell
6,390
$1.75
$11.18K
Thomas Brian C.
6 Jun 2025
Chief Executive Officer
Sell
10,785
$1.75
$18.87K
Wapnick Pamela
6 Jun 2025
Chief Financial Officer
Sell
1,576
$1.75
$2.76K
Noonberg Sarah B.
6 Jun 2025
Chief Medical Officer
Sell
5,239
$1.75
$9.17K
Wein Matthew
6 Jun 2025
See Remarks
Sell
199
$1.75
$348.25
Wapnick Pamela
5 Mar 2025
Chief Financial Officer
Sell
1,808
$1.87
$3.39K
Wein Matthew
5 Mar 2025
See Remarks
Sell
930
$1.87
$1.74K
Wapnick Pamela
5 Dec 2024
Chief Financial Officer
Sell
1,559
$1.86
$2.90K
Wapnick Pamela
5 Sep 2024
Chief Financial Officer
Sell
6,265
$2.88
$18.04K

What was left out

Form 4 filings counted 58
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 26
Transactions with no price 0
Shares from compensation/vesting 8,578,746
History held since 14 Feb 2024